Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3.
Cell Mol Immunol
; 20(2): 189-200, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36600050
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colitis
/
Inflammasomes
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cell Mol Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2023
Document type:
Article